Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |